Scholars Central

Review articlePublished 2014

AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease

Authors: Mark Goodman, Zhenling Liu, Ping Zhu, Ji Li

Pharmaceutical Regulatory Affairs: Open Access

Volume 3 · Issue 2 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease (Graphical abstract).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Mark Goodman”
  • BylineArticles whose byline prints “Zhenling Liu”
  • BylineArticles whose byline prints “Ping Zhu”
  • BylineArticles whose byline prints “Ji Li”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels